Experience
Kaken Pharmaceutical Company Ltd.
Hoechst AG
Finnegan successfully defended Hoechst against patent infringement claims by Kaken Pharmaceuticals in the ITC. Kaken sought to exclude Hoechst’s agricultural feed products containing salinomycin, an antibiotic, from U.S. markets. We persuaded the ITC that the Kaken patents were invalid and unenforceable on the grounds of inequitable conduct. The judge recommended monetary sanctions against Kaken and payable to Hoechst to cover Hoechst’s legal fees and costs to defend the case. The judge also recommended a penalty in an equal amount payable to the ITC. On appeal, the decision against Kaken was affirmed by the Federal Circuit.
Certain Salinomycin Biomass and Preparations Containing Same, 337-TA-370, ITC, Judge Harris
Kaken Pharmaceutical Company Ltd. v. Hoechst AG, 96-1300, -1302, Fed. Cir., Judges Schall, Bryson, Smith
Federal Circuit rules in favor of Finnegan client InterDigital in appeal from ITC case
InterDigital Communications Corp.
Federal Circuit reverses ITC finding in favor of Finnegan client John Mezzalingua Associates
John Mezzalingua Associates, Inc.
Telcordia Technologies
Defending ADT, Actron AG, and Tokai Denshi against attempt to block importation of resonate tags
ADT, Actron AG, Tokai Denshi
ITC victory keeps U.S. market open for Mitsubishi wind turbines
Mitsubishi Heavy Industries, Ltd.
iFlight Technology Company, Ltd. et al. v. ITC
iFlight Technology Company, Ltd. et al.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.